CS logo
small CS logo
Kansai Medical University

Hirakata, Osaka, Japan
Private university in Hirakata
〒573-1191 Osaka, Hirakata, Shinmachi, 2 Chome−3−1

About Kansai Medical University


Kansai Medical University is a private university in Moriguchi, Osaka, Japan. The predecessor of the school was founded in 1928, and it was chartered as a women's medical college in 1947. In 1954 it became coeducational.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Wakayama Medical University
3
University Hospital Inselspital, Berne
2
Kansai Hepatobiliary Oncology Group
1
Kansai Medical University
1
Kyorin University
1
Total Rows: 5

Clinical Trials at Kansai Medical University


During the past decade, Kansai Medical University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2222001100000000Started TrialsCompleted Trails20162017201820190123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Characterization of Macroprolactinemia
2005-01-01
2006-12-01
Completed
A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
2012-04-01
2017-03-01
Completed
38
Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study
2014-04-01
2017-02-01
Completed
10
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
2016-07-11
2025-11-10
Active, not recruiting
146
Study of NAC of GA Therapy for Patients With BRPC
2016-10-01
2021-09-01
Unknown status
60
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
2017-11-06
2024-10-31
Recruiting
2,000
Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer
2017-12-01
2021-11-30
Unknown status
354
Comparison of Optical Coherence Tomography-derived Minimal Lumen Area, Invasive Fractional Flow Reserve and FFRCT
2019-05-28
2026-12-31
Recruiting
104

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kansai Medical University" #1 sponsor was "Wakayama Medical University" with 3 trials, followed by "University Hospital Inselspital, Berne" with 2 trials sponsored, "Kansai Hepatobiliary Oncology Group" with 1 trials sponsored, "Kansai Medical University" with 1 trials sponsored and "Kyorin University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kansai Medical University" #1 collaborator was "Japan Clinical Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsWakayama Medical University: 3Wakayama Medical University: 3University HospitalInselspital, Berne: 2University HospitalInselspital, Berne: 2Kansai HepatobiliaryOncology Group: 1Kansai HepatobiliaryOncology Group: 1Kansai Medical University: 1Kansai Medical University: 1Kyorin University: 1Kyorin University: 1

Created with Highcharts 11.1.0Top CollaboratorsJapan Clinical OncologyGroup: 1Japan Clinical OncologyGroup: 1

Clinical Trials Conditions at Kansai Medical University


According to Clinical.Site data, the most researched conditions in "Kansai Medical University" are "Pancreatic Ductal Adenocarcinoma" (2 trials), "Biliary Tract Cancer" (1 trials), "Coronary Stenosis" (1 trials), "Glioblastoma" (1 trials) and "Hyperprolactinemia" (1 trials). Many other conditions were trialed in "Kansai Medical University" in a lesser frequency.

Clinical Trials Intervention Types at Kansai Medical University


Most popular intervention types in "Kansai Medical University" are "Drug" (5 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)" (1 trials), "FIRINOX" (1 trials), "Gemcitabine, S-1" (1 trials) and "Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kansai Medical University


The vast majority of trials in "Kansai Medical University" are 8 trials for "All" genders.

Clinical Trials Status at Kansai Medical University


Currently, there are NaN active trials in "Kansai Medical University". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kansai Medical University, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kansai Medical University, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 2Not Applicable: 2Phase 1: 2Phase 1: 2Phase 3: 2Phase 3: 2Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Recruiting: 2Recruiting: 2Unknown status: 2Unknown status: 2Active, not recruiting: 1Active, not recruiting: 1